Predicting mortality after hospitalisation for COPD using electronic health records

Pellicori, P. , McConnachie, A. , Carlin, C., Wales, A. and Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, 106199. (doi: 10.1016/j.phrs.2022.106199) (PMID:35381341)

[img] Text
268118.pdf - Published Version
Available under License Creative Commons Attribution.

[img] Other (Spreadsheet)
268118Suppl.xlsx - Supplemental Material

[img] Text
268118Suppl1.pdf - Supplemental Material

[img] Text
268118Suppl2.pdf - Supplemental Material



Background: Few prognostic models exist for patients hospitalised with chronic obstructive pulmonary disease (COPD); most are based on small cohorts enrolled by specialists in academic centres. Electronic health records (EHRs) provide an opportunity to develop more representative models, although they may not record some variables used in existing models. Materials and Methods: for this retrospective cohort study, using EHRs, we identified 17,973 patients with an unplanned hospitalisation for COPD (in any diagnostic position) in the Glasgow area between 2011 and 2017. Patients with known lung cancer were excluded. EHR were linked to prior admissions, community prescribing and laboratory data. A pragmatic, parsimonious multivariable model was developed to predict 90-day mortality. Results: we identified 12 variables strongly related to prognosis, including age, sex, length of index hospitalisation stay, prior diagnosis of cancer (excluding lung cancer) or dementia, prescription of oxygen or digoxin, neutrophil/lymphocyte ratio and serum chloride, urea, creatinine and albumin. The model achieved excellent calibration with reasonable discrimination (area under the curve: 0.806; 95% CI: 0.792 to 0.820). A risk-score was developed and an electronic risk-calculator is provided. Conclusions: a small number of variables, including prescriptions and laboratory data obtained from routine EHRs predict 90-day mortality after a hospitalisation for COPD. The risk-calculator provided might prove useful for service-evaluation and audit, to guide clinical management and to risk-stratify and select patients to be invited to participate in clinical research.

Item Type:Articles
Glasgow Author(s) Enlighten ID:McConnachie, Professor Alex and Carlin, Dr Christopher and Cleland, Professor John and Pellicori, Dr Pierpaolo
Authors: Pellicori, P., McConnachie, A., Carlin, C., Wales, A., and Cleland, J. G.F.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Pharmacological Research
ISSN (Online):1096-1186
Published Online:04 April 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Pharmacological Research 179: 106199
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record